Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0226-2017

Drug recall · December 28, 2016

AMGEN Kyprolis recall

Why: Lack of Assurance of Sterility: Potential cracks in glass vials

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01

Lots / codes

Lot #1071559, 1071629; Exp. 05/18

Quantity
11,434 vials
Company
Amgen, Inc., Thousand Oaks, CA
Distribution
United States and Puerto Rico No foreign distribution.
Initiated
December 15, 2016 · Voluntary: Firm initiated
Classified
December 22, 2016
Reported
December 28, 2016
Ended
June 2, 2017
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.